Results from a post hoc subgroup analysis of the SURMOUNT-1 study (NCT04184622), published this year [87] , demonstrated that among 32 pathogenic MC4R variant carriers (1.4% of the study population) with a median age of 41.06 years and a BMI 40 kg/m 2 , treatment with tirzepatide for 72 weeks resulted in an 18.3% reduction in body weight from baseline
For those committed to optimizing metabolic health through dual-agonist peptides, SeekPeptides members access comprehensive protocol libraries comparing mazdutide, tirzepatide, semaglutide, and emerging alternatives with detailed efficacy data, side effect management strategies refined through thousands of user experiences, personalized dosing calculators that account for individual factors most generic protocols ignore, and real-time updates as new clinical data emerges
Understanding Brand Name GLP-1 Medications: A Clearer Look You've likely heard about medications like Ozempic, Wegovy, and Zepbound recently
Same volume
However, researchers are also exploring whether anti-inflammatory and metabolic effects contribute additional benefits beyond reduced joint stress alone